• Products
  • Suppliers
  • Sourcing Requests
Post Sourcing Request Exhibition
Get alerted on the PharmaSources E-Newsletter and Pharma Sources Insight E-Compilation!
Note: You can unsubscribe from the alerts at any time.
Advertising
New Products
Gelatin, Soft Capsule Gelatin, Hard Capsule Gelatin, Pharmaceutical Gelatin-Foodmate
Neohesperidin
Advantame
Cleanroom Bench Horizontal Laminar Flow Hood Airflow Clean Bench
Pharma and Food Grade, USP/FCC Neotame Sweetener E961
Trilobatin

Israel Says it Sent ‘Completely Normal’ Vaccines to Palestinians

firstwordpharmaJune 21, 2021

Tag: Vaccine , Pfizer , Health Ministry

Israel's Health Ministry said that the first batch of Pfizer's vaccine Israel sent to the Palestinian Authority as part of a larger swap deal was "completely normal" and identical to the vaccines being given to Israeli citizens, Bloomberg reported.

Israel Says it Sent ‘Completely Normal’ Vaccines to Palestinians

The Palestinian Authority cancelled its exchange agreement with Israel as the doses were set to expire this month, leaving its health ministry insufficient time to use them.

However, the ministry said it sent vaccines with expiration dates that were "known, agreed upon and in accordance with the agreement between the parties."

Previous:Eisai, BMS Enter Global Anticancer ADC Alliance

Next:Solvias Acquires Chemic Labs

Related News

Everest Medicines Announces Acceptance of the New Drug Application for VELSIPITY

Everest Medicines LimitedDecember 20, 2024

Everest Medicines announced NMPA acceptance of NDA for VELSIPITY(R) (etrasimod) to treat moderately to severely active UC.

Manulife Hong Kong Partners with New Frontier Group to Enhance Cross-Border Healthcare Services

PRNewswireDecember 12, 2024

Menarini Group and MEDSIR Present the Phase III Study ADELA: A New Therapeutic Strategy for Advanced Breast Cancer

PRNewswireDecember 12, 2024

Israel Says it Sent ‘Completely Normal’ Vaccines to Palestinians | Pharmasources.com

Core8 Group and MedArmor to Pioneer Vietnam's First AI x ESG Hospital

PRNewswireDecember 12, 2024

Core8 Group, an Australian leader in high-tech and biotech innovation, has unveiled plans to develop Vietnam's first AI x ESG Hospital, marking a significant milestone in healthcare transformation.

You may like
More>>

Ruminant Vaccine Series

Ruminant Vaccine Series
Varicella Vaccine, Live

Varicella Vaccine, Live
Recombinant Hepatitis B Vaccine

Recombinant Hepatitis B Vaccine
Poliomyelitis Vaccine (Vero Cell), Inactivated, Sabin Strains

Poliomyelitis Vaccine (Vero Cell), Inactivated, Sabin Strains
Poultry Vaccine Series

Poultry Vaccine Series
Automatic GMP Washing and Drying System Meet Requirement of Pharmaceutical and Vaccine Production

Automatic GMP Washing and Drying System Meet Requirement of Pharmaceutical and Vaccine Production
Swine Vaccine Series

Swine Vaccine Series
Inactivated Hepatitis A Vaccine

Inactivated Hepatitis A Vaccine
Recombinant B-Subunit/Whole Cell Cholera Vaccine(Enteric-coated Capsule)

Recombinant B-Subunit/Whole Cell Cholera Vaccine(Enteric-coated Capsule)
Vi Polysaccharide Typhoid Vaccine

Vi Polysaccharide Typhoid Vaccine

Contact Us

PharmaSources@imsinoexpo.com

Tel: (+86) 400 610 1188

WhatsApp/Telegram/Wechat: +86 13621645194

About Us
About PharmaSources
Terms of Service
Privacy Policy
Intellectual Property
Media Partners
Buy
Search Products
Post Sourcing Requests
Search Suppliers
CAS Search
Sell
Member Application
Advertising
Post Products
EZSourcing
Events
CPHI China
PMEC China
Conferences
Search Events
Help
FAQ
Contact Us
Feedback
PharmaSources Customer Service